Skip to content
MI
Company

Updated:

Molecular Insight Pharmaceuticals, Inc.

Molecular Insight Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001340752, and its...

Overview

Molecular Insight Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001340752, and its reported industry is Pharmaceutical Preparations. The retained history contains 12 filings, including 8-K filed on 2011-05-11. Each filing retains its accession, filing date and original SEC document link. This historical evidence does not establish current registration, listing, ownership or financial condition.

Company overview

Legal name
Molecular Insight Pharmaceuticals, Inc.
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Cambridge, MA, United States
Incorporated in
MA
Fiscal year end
December 31
SEC CIK
0001340752

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
SC 13D—SCHEDULE 13D
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Molecular Insight Pharmaceuticals, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Molecular Insight Pharmaceuticals, Inc. | Company | Altss